EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Hypersensitivity to Excipients in Drugs: An EAACI Position Paper

Lene H Garvey iD, Knut Brockow iD, Annick Barbaud iD, Charlotte G Mortz iD, Gianfranco Calogiuri iD, Asli Gelincik iD, Osman O Yeğit iD, Alla Nakonechna iD, Annette Wagner, Rik Schrijvers iD, Toon Ieven iD

Allergy · 2026-07 · 81 (7) · 2250-2275

DOI: 10.1111/all.70324 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 08.04.2026. Verfasst von Lene H Garvey und 10 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Clinic, Department of Dermatology and Allergy, Herlev and Gentofte University Hospital, Hellerup, Denmark. Hauptthemen laut MEDLINE: Excipients, Drug Hypersensitivity. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, European Academy of Allergy and Clinical Immunology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drugs contain active pharmaceutical ingredients and excipients, compounds which enhance the pharmacokinetics, stability and palatability of the pharmaceutical formulation. While most drug hypersensitivity reactions (DHR) are caused by active ingredients, excipients may also be involved. Excipient‐related DHR are easily overlooked and may lead to repeated anaphylaxis in patients exposed to pharmaceutical formulations containing different active ingredients. We performed an extensive review of the literature to provide practical recommendations on when to suspect and how to diagnose and manage excipient hypersensitivity. Where literature was limited, the collective experience of the authors was taken into consideration. Excipient hypersensitivity should be suspected in patients with a history of anaphylaxis to multiple drugs with chemically unrelated active ingredients and specific drug classes such as oral laxatives and injectable depot steroids or progestogens. Polyethylene glycol, methylcelluloses, gelatine, povidone and mannitol were identified as the most common culprits of DHR. DHR evaluation should include review of the product monograph to ascertain the presence of possible culprit excipients. Specific diagnostic tests for excipients should be performed when appropriate, including skin, in vitro and provocation testing with pure excipients and drugs with and without the excipient as controls. We provide consensus‐based excipient‐specific recommendations on diagnostic testing based on best available evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExcipientsDrug HypersensitivityHumansBulk Drugs

Stichwörter der Autor:innen

drug hypersensitivityexcipientsgelatinemethylcellulosepolyethylene glycol

Substanzen

ExcipientsBulk Drugs

Autor:innen und Institutionen

  • Allergy Clinic, Department of Dermatology and Allergy, Herlev and Gentofte University Hospital, Hellerup, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Dermatology and Allergy Biederstein, Faculty of Medicine and Health, Technical University Munich, Munich, Germany.
  • Service de Dermatologie et Allergologie, Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Hôpital Tenon AP-HP, Sorbonne Université, Paris, France.
  • Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark.
  • Research Unit Dermatology and Allergology, University of Southern Denmark, Odense, Denmark.

ORCID-Profile: Lene H Garvey, Knut Brockow, Annick Barbaud, Charlotte G Mortz, Gianfranco Calogiuri, Asli Gelincik, Osman O Yeğit, Alla Nakonechna, Rik Schrijvers, Toon Ieven

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • European Academy of Allergy and Clinical Immunology

Zitieren

APA

Garvey, L. H., Brockow, K., Barbaud, A., Mortz, C. G., Calogiuri, G., Gelincik, A., Yeğit, O. O., Nakonechna, A., Wagner, A., Schrijvers, R., & Ieven, T. (2026). Hypersensitivity to Excipients in Drugs: An EAACI Position Paper. Allergy, 81(7), 2250-2275. https://doi.org/10.1111/all.70324

Vancouver

Garvey LH, Brockow K, Barbaud A, Mortz CG, Calogiuri G, Gelincik A, et al. Hypersensitivity to Excipients in Drugs: An EAACI Position Paper. Allergy. 2026;81(7):2250-2275. doi:10.1111/all.70324

BibTeX
@article{Garvey2026,
  author = {Garvey, Lene H and Brockow, Knut and Barbaud, Annick and Mortz, Charlotte G and Calogiuri, Gianfranco and Gelincik, Asli and Yeğit, Osman O and Nakonechna, Alla and Wagner, Annette and Schrijvers, Rik and Ieven, Toon},
  title = {Hypersensitivity to Excipients in Drugs: An EAACI Position Paper},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {7},
  pages = {2250--2275},
  doi = {10.1111/all.70324}
}
Kostenlos starten →